House bill HR7658-117

Energy and Commerce Committee

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

• Last activity on May 03, 2022

• Introduced May 03, 2022

• By Rep. O'Halleran, Tom [D-AZ-1]

Support this bill

Main Subject: Health

This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.

HR7667-117, S4152-117, S4348-117,

House floor actions Actions

IntroReferral
May. 03 2022	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

IntroReferral
May. 03 2022	Introduced in House Introduced in House

House bill HR7658-117

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Promote the cause!

Or use this QR code